Erysipelas: Difference between revisions

No edit summary
Line 2: Line 2:
*Specific form of cellulitis involving the epidermis, upper levels of the dermis, and the lymphatics
*Specific form of cellulitis involving the epidermis, upper levels of the dermis, and the lymphatics
*Most often caused by strep
*Most often caused by strep
*Bullous erysipelas, a more severe form of the disease, is often caused by staph (and MRSA)
**Bullous erysipelas, a more severe form of the disease, is often caused by staph (and MRSA)


==Diagnosis==
==Clinical Features==
*Often accompanied by fever, chills, malaise, HA, vomiting
*Rash
*Rash
**Local redness, heat, swelling
**Local redness, heat, swelling
**Sharp raised and indurated border
**Sharp raised and indurated border
*Can be accompanied by fever, chills, malaise, headache, nausea/vomiting


==Differential Diagnosis==
==Differential Diagnosis==
{{Template:SSTI DDX}}
{{Template:SSTI DDX}}


==Treatment==
==Diagnosis==
*Clinical diagnosis, based on history and physical exam
 
==Management==
===[[Antibiotics]]===
===[[Antibiotics]]===
{{Erysipelas antibiotics}}
{{Erysipelas antibiotics}}


==Source==
==Disposition==
*Tintinalli
*Generally may be discharged with outpatient treatment
 
==See Also==
 
 
==References==
<References/>


[[Category:Peds]]
[[Category:Derm]]
[[Category:Derm]]

Revision as of 07:19, 22 August 2015

Background

  • Specific form of cellulitis involving the epidermis, upper levels of the dermis, and the lymphatics
  • Most often caused by strep
    • Bullous erysipelas, a more severe form of the disease, is often caused by staph (and MRSA)

Clinical Features

  • Rash
    • Local redness, heat, swelling
    • Sharp raised and indurated border
  • Can be accompanied by fever, chills, malaise, headache, nausea/vomiting

Differential Diagnosis

Skin and Soft Tissue Infection

Look-A-Likes

Diagnosis

  • Clinical diagnosis, based on history and physical exam

Management

Antibiotics

Coverage for S. pyogenes

  • Penicillin G 300K U/d IM for <30 kg, 600K to 1 million U/d IM for >30 kg (first line therapy[1]) OR
  • Clindamycin 450mg (5mg/kg) PO q8hrs x 10 days (if PCN allergic) OR
  • Cephalexin 500mg (6.25mg/kg) PO q6hrs x 10 days OR
  • Ceftriaxone 1g (50mg/kg) IV once daily x 10 days OR
  • Levofloxacin 500mg PO/IV daily x 10 days OR
  • Augmentin 500mg PO BID x 10 days (generally reserved for failure of first line therapy)

Bullous Erysipela or MRSA suspected: trimethoprim-sulfamethoxazole, clindamycin, doxycycline, or minocycline

Disposition

  • Generally may be discharged with outpatient treatment

See Also

References

  1. Linke M, Booken N. Risk factors associated with a reduced response in the treatment of erysipelas. J Dtsch Dermatol Ges. 2015 Mar;13(3):217-25.